Estimated Impact of Public and Private Sector COVID-19 Diagnostics and Treatments on US Healthcare Resource Utilization.

Szczegóły
Abstrakt

Tytuł:: Estimated Impact of Public and Private Sector COVID-19 Diagnostics and Treatments on US Healthcare Resource Utilization.
Autorzy:: Sheinson DM; Genentech, Medical Affairs, South San Francisco, CA, USA. .
Wong WB; Genentech, Medical Affairs, South San Francisco, CA, USA.
Solon CE; Genentech, Medical Affairs, South San Francisco, CA, USA.
Cheng MM; Roche Molecular Systems, Inc, Global Access and Health Economics, Pleasanton, CA, USA.
Shah A; Genentech, Medical Affairs, South San Francisco, CA, USA.
Elsea D; Bresmed, Health Economic Analysis, Las Vegas, NV, USA.
Meng Y; Bresmed, Health Economic Analysis, Las Vegas, NV, USA.
Źródło:: Advances in therapy [Adv Ther] 2021 Feb; Vol. 38 (2), pp. 1212-1226. Date of Electronic Publication: 2020 Dec 26.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
Język:: English
Imprint Name(s):: Publication: New York : Springer Healthcare Communications, 2008- : Health Communications Inc.
Original Publication: Metuchen, N.J. : Health Communications Inc., c1984-
MeSH Terms:: Health Services Needs and Demand*
Private Sector*
Public Sector*
COVID-19/*diagnosis
COVID-19/*therapy
Health Resources/*statistics & numerical data
COVID-19/mortality ; COVID-19 Testing/statistics & numerical data ; Health Policy ; Hospital Bed Capacity ; Hospitalization ; Humans ; Intensive Care Units/statistics & numerical data ; Length of Stay ; Mortality ; Patient Acceptance of Health Care ; Respiration, Artificial ; SARS-CoV-2 ; Surge Capacity ; United States ; Ventilators, Mechanical
References:: JAMA. 2020 Apr 7;323(13):1239-1242. (PMID: 32091533)
N Engl J Med. 2021 Feb 11;384(6):497-511. (PMID: 33264556)
BMJ. 2020 Oct 19;371:m4057. (PMID: 33077424)
J Glob Health. 2020 Jun;10(1):010377. (PMID: 32582439)
N Engl J Med. 2020 Sep 3;383(10):994. (PMID: 32649078)
Ann Intensive Care. 2017 Dec;7(1):46. (PMID: 28466462)
Proc Natl Acad Sci U S A. 2020 Apr 21;117(16):9122-9126. (PMID: 32245814)
Int J Nurs Stud. 2018 Feb;78:76-83. (PMID: 29110907)
Health Aff (Millwood). 2020 Jul;39(7):1247-1252. (PMID: 32352846)
Int J Equity Health. 2020 Jun 26;19(1):104. (PMID: 32586388)
Ann Intern Med. 2020 Jul 7;173(1):21-28. (PMID: 32259197)
Ann Intensive Care. 2020 Mar 18;10(1):33. (PMID: 32189136)
Otolaryngol Head Neck Surg. 2020 Jul;163(1):65-66. (PMID: 32366172)
BMJ. 2020 May 29;369:m1996. (PMID: 32471884)
N Engl J Med. 2020 May 21;382(21):2049-2055. (PMID: 32202722)
JAMA. 2002 Oct 23-30;288(16):1987-93. (PMID: 12387650)
JAMA Intern Med. 2020 Nov 1;180(11):1436-1447. (PMID: 32667668)
Chest. 1996 Aug;110(2):469-79. (PMID: 8697853)
Clin Infect Dis. 2021 May 4;72(9):e206-e214. (PMID: 32674114)
Lancet. 2020 Jun 6;395(10239):1763-1770. (PMID: 32442528)
Health Aff (Millwood). 2020 Aug;39(8):1443-1449. (PMID: 32525713)
Euro Surveill. 2020 Mar;25(10):. (PMID: 32183930)
Contributed Indexing:: Keywords: COVID-19; Diagnostic test; Health policy; Health resources
Entry Date(s):: Date Created: 20201228 Date Completed: 20210226 Latest Revision: 20231110
Update Code:: 20240105
PubMed Central ID:: PMC7765700
DOI:: 10.1007/s12325-020-01597-3
PMID:: 33367984
: Czasopismo naukowe

Full Text Finder

Introduction: Coronavirus disease 2019 (COVID-19) has imposed a considerable burden on the United States (US) health system, with particular concern over healthcare capacity constraints.
Methods: We modeled the impact of public and private sector contributions to developing diagnostic testing and treatments on COVID-19-related healthcare resource use.
Results: We estimated that public sector contributions led to at least 30% reductions in COVID-19-related healthcare resource utilization. Private sector contributions to expanded diagnostic testing and treatments led to further reductions in mortality (- 44%), intensive care unit (ICU) and non-ICU hospital beds (- 30% and - 28%, respectively), and ventilator use (- 29%). The combination of lower diagnostic test sensitivity and proportions of patients self-isolating may exacerbate case numbers, and policies that encourage self-isolating should be considered.
Conclusion: While mechanisms exist to facilitate research, development, and patient access to diagnostic testing, future policies should focus on ensuring equitable patient access to both diagnostic testing and treatments that, in turn, will alleviate COVID-19-related resource constraints.

Informacja